Real-time enrollment status for this eosinophilic esophagitis (eoe) clinical trial
Current Status
Recruiting
Checked: July 13, 2026 at 6:37 AM UTC
| NCT Number | NCT07112378 |
| Recruiting Status | Recruiting |
| Condition | Eosinophilic Esophagitis (EoE) |
| Phase | Clinical Trial |
| Target Enrollment | 20 participants |
| Active Locations | 11 sites in the US |
| Sponsor | Regeneron Pharmaceuticals |
| Last Updated on CT.gov | July 6, 2026 (1 week ago) |
As of July 13, 2026: Clinical trial NCT07112378 is currently recruiting participants. This clinical trial study for eosinophilic esophagitis (eoe) is actively seeking new participants at 11 locations across the United States. The study is sponsored by Regeneron Pharmaceuticals. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07112378 is actively recruiting participants as of July 13, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 11 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07112378 was last updated 1 week ago (July 6, 2026). HelloStudys verifies this status automatically.